A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer
Recruiting
480 enrolled
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
Completed
377 enrolled
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Recruiting
1,100 enrolled
TraveraRTGx
Completed
72 enrolled
Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies
Enrolling by invitation
500 enrolled
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
Completed
40 enrolled
ASAP
Recruiting
25,000 enrolled
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Suspended
22 enrolled
PRO-ACTIVE
Recruiting
850 enrolled
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Recruiting
25 enrolled
iCaRe2
Recruiting
999,999 enrolled
EXoPERT EMERALD Clinical Study
Recruiting
1,400 enrolled
CAMPERR
Recruiting
7,000 enrolled
SCORE
Recruiting
9,600 enrolled
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
Active not recruiting
992 enrolled
LIBERATE
Recruiting
2,500 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
PROGECT
Recruiting
1,500 enrolled
OvAR-Y
Recruiting
10 enrolled
Assessing the Time Demands of Cancer
Active not recruiting
78 enrolled 8 charts
COSMOS
Not yet recruiting
248 enrolled
OLAP
Completed
661 enrolled
Clinical Significance of Germline BRCA Mutations
Active not recruiting
13,320 enrolled
PRIORITY
Completed
346 enrolled 9 charts
START
Terminated
10 enrolled
Assessment of Paclitaxel-Induced Neuropathy
Active not recruiting
43 enrolled
Early Ageing During Therapy in AYA Cancer Patients
Recruiting
120 enrolled
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
Recruiting
3,300 enrolled
Tempus Priority Study: A Pan-tumor Observational Study
Active not recruiting
1,000 enrolled
SURVIMON
Active not recruiting
100,000 enrolled
Improved Early Diagnosis in Female Pelvic Cancer With OC Detect
Completed
490 enrolled
LONGEVITI
Recruiting
75 enrolled
Genomic Testing and Resulting Medical Decisions
Completed
1,500 enrolled
A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer
Withdrawn
PREFER
Completed
1,429 enrolled
INSPIRE
Recruiting
5,350 enrolled
Evaluating Scaleup of an Adapted Breast Cancer Early Diagnosis Program in Rwanda
Completed
2,357 enrolled
MOHCCN-O
Recruiting
500 enrolled
REFLECT
Recruiting
120 enrolled
Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers
Recruiting
100 enrolled
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
Recruiting
15,000 enrolled
ROOT
Completed
167 enrolled
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Withdrawn
QUANTUM
Enrolling by invitation
3,000 enrolled
Gene-HEART
Completed
79 enrolled
Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives
Completed
46 enrolled
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Completed
17,667 enrolled
CER
Recruiting
15,000 enrolled
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Unknown
2,700 enrolled
STILVARCA
Active not recruiting
275 enrolled